Pharminent

Pieris Pharmaceuticals and Servier Forge Strategic Immuno-oncology Co-development Alliance

[Marketwired] – Pieris and Servier, an independent international pharmaceutical company headquartered in France with annual sales of more than EUR4 billion, to jointly pursue several bispecific therapeutic programs including … http://finance.yahoo.com/news/pieris-pharmaceuticals-servier-forge-strategic-120000715.html

Filed under: Cancer, Immunotherapy